1. Dr. Juan Pablo de Torres Servicio de Neumología Clínica Universidad de NavarraCOPD and Lung Cancer: One agent with two outcomes: or is it? 2. Resumen •La magnitud…
91 Leading Article Molecular Biomarkers for the Treatment of Lung Cancer: Personalized Therapy Beyond the EGFR Mutation Kenichi Suda, MD, PhD^l and Tetsuya Mitsudomi, MD,…